Ultra-rapid opiate detoxification: From clinical applications to basic science

Addiction Biology

Volumn 8, Issue 2, 2003, Pages 141-146

  Streel, Emmanuel ^a,b   Verbanck, Paul ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CLONIDINE; NALOXONE; NALTREXONE; OPIATE ANTAGONIST;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; AWARENESS; CONTROLLED STUDY; DRUG ABUSE; DRUG DETOXIFICATION; DRUG EFFECT; DRUG WITHDRAWAL; EXPERIENCE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SEDATION;

HUMANS; METABOLIC DETOXICATION, DRUG; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; TIME FACTORS;

EID: 0038824757     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/1355621031000117365     Document Type: Review

References (43)

1. Kurland AA, McCabe L. Rapid detoxification of the narcotic addict with naloxone hydrochloride: a preliminary report. Clin Pharmacol 1976;16:66-75.
2. Blachley P, Casey D, Marcel L, et al. Rapid detoxification from heroin and methadone using naltrexone. A model for study of the treatment of the opiate abstinence syndrome. In: Senay E, Shorty, Alkesne H, editors. Developments in the field of drug abuse. Cambridge, MA: Schenkman Publishing Co; 1975, pp. 327-36.
3. Resnick RB, Kestenbaum RS, Washton A, Poole D. Naloxone-precipitated withdrawal: A method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977;21:409-13.
4. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naloxone. Lancet 1980;5:1079-80.
5. Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours minimal drop-out, using modification of the naltrexoneclonidine technique. Br J Psychiatry 1988;153:340-3.
6. Loimer N, Schmid R, Presslich O, Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatry Res 1989;23:81-86.
7. Loimer N, Schmid R, Lenz K, Presslich O, Grünberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 1990;157:748-52.
8. Loimer N, Lenz K, Schmid R, Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatry 1991;148:933-5.
9. Loimer N, Linzmayer L, Grünberger J. Similar efficacy of abrupt and gradual opiate detoxification. Am J Drug Alcohol Abuse 1991;17:307-12.
10. Brewer C. Ultra-rapid antagonist-precipitated opiate detoxification under general anesthesia or sedation. Addict Biol 1997;2:291-302.
11. Loimer N, Presslich O, Lenz K, Pfersmann D, Schmid R, Fodor G, Aschauer G. Induced detoxification treatment of opiate dependent patients [in German]. Wien Klin Wochenschr 1989;101:451-4.
12. Spanagel R, Kirschke C, Tretter F, Holsboer F. Forced opiate withdrawal under anesthesia augments and prolongs the occurrence of withdrawal signs in rats. Drag Alcohol Depend 1998;52:251-6.
13. Streel E, Bredas P, Dan B, Hanak C, Pelc I, Verbanck P. Previous anesthesia can temporary overshadow the expression of a withdrawal syndrome in opiate dependent rats. Life Sci 2000;67:2883-7.
14. Streel E, Dan B, Bredas P, Clement B, Pelc I, Verbanck P. Interference with withdrawal signs of naloxone-induced opiate withdrawal under anesthesia is anesthetic-specific in opiate dependent rats. Life Sci 2001;70:517-22.
15. Spanagel R. Is there a pharmacological basis for therapy with rapid opioid detoxification? Lancet 1999;354:2017-18.
16. Sargant W, Slater E. An introduction to physical methods of treatment in psychiatry. Edinburgh: E & S Livingstone Ltd, 1944.
17. Mayor S. Specialists criticise treatment for heroin addiction. Br Med J 1997;314:1365.
18. Brewer C, Williams J, Carreno Rendueles E, Garcia JB. Unethical promotion of rapid opiate detoxification under anaesthesia (RODA). Lancet 1998;351:208.
19. Cucchia At, Monnat M, Spagnoli J, Ferrero F, Bertschy G. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Drug Alcohol Depend 1998;52:243-50.
20. Carreno JE, Bobes J, Brewer C, et al. 24-hour opiate detoxification and antagonist induction at home-the "Asturian method": a report on 1368 procedures. Addict Biol 2002;97:1071-3.
21. Gossop M, Strang J. Rapid-anesthetics antagonists detoxification of heroin addicts: what origin, evidence base and clinical justification? Br J Intens Care 1997;3:66-9.
22. Seoane A, Carrasco G, Cabre L, et al. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997;171:340-5.
23. Lorenzi P, Marsili M, Boncinelli S, et al. Searching for a general anesthesia protocol for rapid detoxification from opioids. Eur J Anaesthesiol 1999;16:719-27.
24. Partridge B, Ward C. Pulmonary edema following low-dose naloxone administration. Anesthesiology 1986;65:709.
25. Dyer C. Addict died after rapid opiate detoxification. Br Med J 1998;316:170.
26. Tseng LF, Loh HH, Wei ET. Effects of clonidine on morphine withdrawal signs in the rat. Eur J Pharmacol 1975;30:93-9.
27. Legarda JJ, Gossop M. A 24H inpatient detoxification treatment for heroin addicts: a preliminary investigation. Drug Alcohol Depend 1994;35:91-3.
28. Loimer N, Hofman, N, Chaudry H. Ultrashort non-invasive opiate desintoxication. Am J Psychiatry 1993;150:839.
29. Tretter F, Burkhardt D, Bussello-Spieth B, Reiss J, Walcher S, Buchele W. Clinical experience with antagonist-induced opiate withdrawal under anesthesia. Addiction 1998;93:269-75.
30. Streel E, Pelc I, Verbanck P. Towards a comprehension concerning the clinical effects of therapy with rapid opioid detoxification. Addict Biol 2001;6:385.
31. Maldonado R, Stinus L, Koob GF. Neurobiological mechanism of opiate withdrawal. New York: Springer, 1996.
32. Bearn J, Bennet T, Martin M, Gossop M, Strang J. The impact of naloxone/lofexifine combination treatment on the opiate withdrawal syndrome. Addict Biol 2001;6:147-57.
33. Cruz SL, Villareal JE, Volkow ND. Further evidence that naloxone act as an inverse opiate agonist: implication for drug dependence and withdrawal. Life Sci 1996;8:381-9.
34. Foo H, Westbrook RF. Naloxone-induced hypoanalgesia: effects of noradrenergic antagonists and agonists. Pharmacol Biochem Behav 1991;39:795-7.
35. Sakai F, Amaha K. Midazolam and ketamine inhibit glutamate release via a cloned human brain glutamate transporter. Can J Anaesth 2000;47:800-6.
36. Hanak C, Streel E, Tecco J, et al. Int Neuropsychopharmacology 2000;3:327.
37. Pelc I, Streel E, Tecco J, Massaut J, Verbanck P. Description of an inpatient setting of rapid induction of opiate antagonist in a general hospital: the Brugmann's experience. Advances in antagonists-assisted abstinence; rapid opiate detoxification and naltrexone treatment. Abstract Book. London: Stapleford Trust, 2001.
38. Currie J, Collins L, Mudaliar Y, et al. Rapid induction onto naltrexone: a randomised clinical trial of anesthesia-assisted versus sedation-assisted techniques, and a comparison with conventional detoxification. Western Sydney Area Health Service Drug and Alcohol Service - Report to government of New South Wales, 2000.
39. Javier Alvarez F, Carmen Del Rio M, San L, Arranz B. Ultrarapid opiate detoxification: a look at what is happening in Spain. Pros and cons of ultrarapid opiate detoxification. Addiction 1999;94:1239-41.
40. Laheij R, Krabbe P, De Jonge C. Rapid heroin detoxification under general anesthesia. JAMA 2000;283:1143.
41. Hulse G, O'Neil G, Using naltrexone implants in the management of the pregnant heroin user. Aust NZ J Obstet Gyn 2002;42:569-73.
42. Kranzler HB, Modesto-Lowe V, Nuwayser E. Sustained-release naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 1998;22:1074-9.
43. Greenberg M. Ultra-rapid opioid detoxification of two children with congenital heart disease. J Addict Dis 2000;19:53-8.